Matisse Capital Orchard Therapeutics PLC Transaction History

Matisse Capital

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 12, 2022	SELL	$0.7 - $1.51 $7,000 - $15,100	-10,000 Closed	0 $0
Q4 2021 Feb 04, 2022	SELL	$1.16 - $2.23 $4,640 - $8,920	-4,000 Reduced 28.57%	10,000 $13,000
Q2 2021 Aug 11, 2021	SELL	$4.39 - $7.23 $1,975 - $3,253	-450 Reduced 3.11%	14,000 $61,000
Q4 2020 Feb 12, 2021	BUY	$3.86 - $5.07 $1,737 - $2,281	450 Added 3.21%	14,450 $62,000
Q3 2020 Nov 04, 2020	BUY	$4.11 - $6.45 $57,540 - $90,300	14,000 New	14,000 $58,000
Q2 2020 Jul 28, 2020	SELL	$5.75 - $11.99 $220,081 - $458,917	-38,275 Closed	0 $0
Q1 2020 May 07, 2020	BUY	$5.65 - $15.71 $7,203 - $20,030	1,275 Added 3.45%	38,275 $288,000
Q4 2019 Feb 12, 2020	BUY	$10.15 - $15.58 $375,550 - $576,460	37,000 New	37,000 $509,000

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Matisse Capital, based on Form 13F filings with the SEC.

Stay updated on Matisse Capital with notifications on news.